| abstract |
The present invention relates to a pharmaceutical composition comprising a steroid drug, such as drospirenone, in molecularly dispersed form. Preferably, the composition is provided as a solid, semi-solid or liquid form, which is then applied for oral administration and is preferably absorbed from the gastrointestinal tract. Such compositions have been found to have high bioavailability, good chemical stability, and rapid in vitro lysis release and are manufactured under conditions that do not require expensive equipment or safety guards. can do. |